Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262002
Status:
COMPLETED
Last Update Posted:
2014-06-18
First Post:
2005-12-02
Brief Title:
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants
Sponsor:
Novartis Vaccines
Organization:
Novartis
Study Overview
Official Title:
A Phase II Randomized Open Label Controlled Multicenter Study to Evaluate the Safety Immunogenicity and Induction of Immunological Memory After Two or Three Doses of Novartis Formerly Chiron Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants at 2 3 4 or 2 4 6 Months of Age
Status:
COMPLETED
Status Verified Date:
2014-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety immunogenicity and induction of immune memory after two or three doses of Novartis Formerly Chiron Meningococcal ACWY Conjugate Vaccine administered to healthy infants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-000195-13 | None | None | None |